UPDATE: Morgan Stanley Downgrades Foghorn Therapeutics (FHTX) to Equalweight
Tweet Send to a Friend
(Updated - August 23, 2022 2:33 PM EDT)
Morgan Stanley analyst Vikram Purohit downgraded Foghorn Therapeutics (NASDAQ: FHTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Vikram Purohit downgraded Foghorn Therapeutics (NASDAQ: FHTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
